Products
Online Inquiry
FLLL32
Inquiry
Cat. No.:
OB0125LY-081
Size:
2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg
CAS No.:
1226895-15-3
Compound CID:
68019246
Specification
Description:
FLLL32 is an effective JAK2/STAT3 inhibitor and acts by binding to interferon-induced kinases such as JAKs, thereby inhibiting their activity.
Formula Weight:
464.55
Stability:
3 years in powder form.
Applications:
FLLL32 can be used to study cell signaling, especially in tumor biology and immune regulation.
Storage:
Storage at -20°C.
Formula:
C28H32O6
Appearance:
Solid
Purity:
99.8%
Identity:
Confirmed by NMR and HPLC.
Targets&IC50:
JAK2: <5 μM
Library Information
Plate Number:
AOCL-13
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Formulation:
10mM DMSO
Container:
96-well plate
Pathways:
Apoptosis; Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem cells
Targets:
JAK; STAT; Apoptosis
Receptors:
Apoptosis; JAK; JAK2; STAT
DMSO Max Solubility (mg/mL):
85 mg/mL
DMSO Max Solubility (mM):
183 mM
Water Max Solubility (mg/mL):
1 mg/mL
Ethanol Max Solubility (mg/mL):
24 mg/mL
Ethanol Max Solubility (mM):
51.7 mM
ALogP:
5.882
HBA_Count:
6
Rotatable Bond:
10